PURPOSE: To characterize the functional role of c-Jun NH(2)-terminal kinase (JNK) and other apoptotic pathways in grape seed extract (GSE)-induced apoptosis in human leukemia cells by using pharmacologic and genetic approaches. EXPERIMENTAL DESIGN: Jurkat cells were treated with various concentrations of GSE for 12 and 24 h or with 50 microg/mL GSE for various time intervals, after which apoptosis, caspase activation, and cell signaling pathways were evaluated. Parallel studies were done in U937 and HL-60 human leukemia cells. RESULTS: Exposure of Jurkat cells to GSE resulted in dose- and time-dependent increase in apoptosis and caspase activation, events associated with the pronounced increase in Cip1/p21 protein level. Furthermore, treatment of Jurkat cells with GSE resulted in marked increase in levels of phospho-JNK. Conversely, interruption of the JNK pathway by pharmacologic inhibitor (e.g., SP600125) or genetic (e.g., small interfering RNA) approaches displayed significant protection against GSE-mediated lethality in Jurkat cells. CONCLUSIONS: The result of the present study showed that GSE induces apoptosis in Jurkat cells through a process that involves sustained JNK activation and Cip1/p21 up-regulation, culminating in caspase activation.
PURPOSE: To characterize the functional role of c-Jun NH(2)-terminal kinase (JNK) and other apoptotic pathways in grape seed extract (GSE)-induced apoptosis in humanleukemia cells by using pharmacologic and genetic approaches. EXPERIMENTAL DESIGN:Jurkat cells were treated with various concentrations of GSE for 12 and 24 h or with 50 microg/mL GSE for various time intervals, after which apoptosis, caspase activation, and cell signaling pathways were evaluated. Parallel studies were done in U937 and HL-60humanleukemia cells. RESULTS: Exposure of Jurkat cells to GSE resulted in dose- and time-dependent increase in apoptosis and caspase activation, events associated with the pronounced increase in Cip1/p21 protein level. Furthermore, treatment of Jurkat cells with GSE resulted in marked increase in levels of phospho-JNK. Conversely, interruption of the JNK pathway by pharmacologic inhibitor (e.g., SP600125) or genetic (e.g., small interfering RNA) approaches displayed significant protection against GSE-mediated lethality in Jurkat cells. CONCLUSIONS: The result of the present study showed that GSE induces apoptosis in Jurkat cells through a process that involves sustained JNK activation and Cip1/p21 up-regulation, culminating in caspase activation.
Authors: Amy M Mingo-Sion; Peter M Marietta; Erich Koller; Douglas M Wolf; Carla L Van Den Berg Journal: Oncogene Date: 2004-01-15 Impact factor: 9.867
Authors: Letteria Minutoli; Domenica Altavilla; Herbert Marini; Maria Passaniti; Alessandra Bitto; Paolo Seminara; Francesco S Venuti; Ciro Famulari; Antonio Macrì; Antonino Versaci; Francesco Squadrito Journal: Life Sci Date: 2004-10-29 Impact factor: 5.037
Authors: A-M Engelbrecht; M Mattheyse; B Ellis; B Loos; M Thomas; R Smith; S Peters; C Smith; K Myburgh Journal: Cancer Lett Date: 2007-10-17 Impact factor: 8.679
Authors: Girish Sharma; Anil K Tyagi; Rana P Singh; Daniel C F Chan; Rajesh Agarwal Journal: Breast Cancer Res Treat Date: 2004-05 Impact factor: 4.872
Authors: Senping Cheng; Ning Gao; Zhuo Zhang; Gang Chen; Amit Budhraja; Zunji Ke; Young-ok Son; Xin Wang; Jia Luo; Xianglin Shi Journal: Clin Cancer Res Date: 2010-12-01 Impact factor: 12.531